Clinical guidelines: should 5 alpha-reductase inhibitors be used for prostate disease?
Clarke
Noel W
NW
D013741:3-Oxo-5-alpha-Steroid 4-Dehydrogenase / Q000378:metabolism; D058891:5-alpha Reductase Inhibitors; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D008297:Male; D017410:Practice Guidelines as Topic / Q000592:standards; D011469:Prostatic Diseases / Q000188:drug therapy* / Q000201:enzymology*
D058891:5-alpha Reductase Inhibitors; D004791:Enzyme Inhibitors; D013741:3-Oxo-5-alpha-Steroid 4-Dehydrogenase